• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Big Reorg Announcement today?

Quote




wow. Still resorting to name calling...what, are you in 3rd grade? No wonder MRK is going down hill quickly. Let me remind you of the facts: j/j/j now have generic competition, it may not be 2016 but wait until 2017 to see the market share plummet; belsoma is well below plan and doesn't look like it will ever grow at the pace that marketing is projecting; zetia is going off patent and the fact the the FDA most likely will not allow the "great" study into our label doesn't give much selling beyond Q3; and the pipeline...well it doesn't look good for the next 12-18 months. Omari (qd-januvia) is not looking like it will ever get the go ahead vote. The SGLT2s are eating a lot of the new market sahre that we are hoping to get. Sure we have the refills on current scripts but doctors are becoming much more comfortable selecting the newest class of meds. Let me know what else I have missed...
 




















You really are immature, ignorant and seems as if your head is stuck in the sand! If you want to stick around while they rearrange the deck chairs on the Titanic...be my guest. Tell me what is going to solidify your job after 2016? HINT: it's not Zetia, belsoma is not the money maker they were hoping for and j/j/j is going to take a huge hit after the end of the year because that is when a majority of the manage care contracts will begins/end. Believe you me that those contracts will be re-negotiated thoroughly for 2017! Good luck my friends and be well.
 




anonymous said:
You really are immature, ignorant and seems as if your head is stuck in the sand! If you want to stick around while they rearrange the deck chairs on the Titanic...be my guest. Tell me what is going to solidify your job after 2016? HINT: it's not Zetia, belsoma is not the money maker they were hoping for and j/j/j is going to take a huge hit after the end of the year because that is when a majority of the manage care contracts will begins/end. Believe you me that those contracts will be re-negotiated thoroughly for 2017! Good luck my friends and be well.
Click to expand...

Be well
 
















anonymous said:
You really are immature, ignorant and seems as if your head is stuck in the sand! If you want to stick around while they rearrange the deck chairs on the Titanic...be my guest. Tell me what is going to solidify your job after 2016? HINT: it's not Zetia, belsoma is not the money maker they were hoping for and j/j/j is going to take a huge hit after the end of the year because that is when a majority of the manage care contracts will begins/end. Believe you me that those contracts will be re-negotiated thoroughly for 2017! Good luck my friends and be well.
Click to expand...

I Smell a political hack, who's unemployed and Dickless. Sniff that Turd breath !!!!
 
























Top Bottom
Back
Quote